Therefore, therapeutic interventions targeting SLC7A9 are promising for sensitising gastric cancer cells to ferroptosis and chemotherapy treatment, and ultimately, improving the prognosis of patients with gastric cancer. The gene discussed is SLC7A9; the disease is gastric cancer.